Clinical Trial Update: Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane

View source ↗

Summary

This clinical trial evaluates whether plasma procalcitonin can predict intra-amniotic infection in women with preterm premature rupture of membranes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-amniotic Infection
• Preterm Birth
• Preterm Premature Rupture of Membranes

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Intra-amniotic Subclinical Infection. | Status: UNKNOWN